Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Pefloxacin Mesylate Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Pefloxacin Mesylate Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 99 Pages

Report ld: 1347505

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Pefloxacin Mesylate is a quinolone antibacterial drug that can treat various infections caused by pefloxacin-sensitive bacteria, such as urinary tract infections and respiratory tract infections.

Pefloxacin Mesylate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pefloxacin Mesylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Pefloxacin Mesylate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Pefloxacin Mesylate key manufacturers include AdvaCare Pharma, China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Yichang Renfu Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Group Saite Co., Ltd., CommScope Pharmaceutical Co., Ltd., Beijing Shuanglu Pharmaceutical Co., Ltd. and Beijing Sihuan Pharmaceutical Co., Ltd., etc. AdvaCare Pharma, China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., Ruiyang Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.

Pefloxacin Mesylate can be divided into Tablet, Capsule and Injection,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.

Pefloxacin Mesylate is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Others,, etc. Hospital Pharmacy provides greatest supports to the Pefloxacin Mesylate industry development. In 2022, global % sales of Pefloxacin Mesylate went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pefloxacin Mesylate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
AdvaCare Pharma
China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
Ruiyang Pharmaceutical Co., Ltd.
Yichang Renfu Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
CommScope Pharmaceutical Co., Ltd.
Beijing Shuanglu Pharmaceutical Co., Ltd.
Beijing Sihuan Pharmaceutical Co., Ltd.

Segment by Type
Tablet
Capsule
Injection

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others

Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Pefloxacin Mesylate market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pefloxacin Mesylate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pefloxacin Mesylate industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Pefloxacin Mesylate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pefloxacin Mesylate introduction, etc. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Pefloxacin Mesylate market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Pefloxacin Mesylate Market Overview
    1.1 Pefloxacin Mesylate Product Overview
    1.2 Pefloxacin Mesylate Market Segment by Type
        1.2.1 Tablet
        1.2.2 Capsule
        1.2.3 Injection
    1.3 Global Pefloxacin Mesylate Market Size by Type
        1.3.1 Global Pefloxacin Mesylate Market Size Overview by Type (2018-2029)
        1.3.2 Global Pefloxacin Mesylate Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Pefloxacin Mesylate Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Pefloxacin Mesylate Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Pefloxacin Mesylate Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Pefloxacin Mesylate Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Pefloxacin Mesylate Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Pefloxacin Mesylate Sales Breakdown by Type (2018-2023)

 2 Global Pefloxacin Mesylate Market Competition by Company
    2.1 Global Top Players by Pefloxacin Mesylate Sales (2018-2023)
    2.2 Global Top Players by Pefloxacin Mesylate Revenue (2018-2023)
    2.3 Global Top Players by Pefloxacin Mesylate Price (2018-2023)
    2.4 Global Top Manufacturers Pefloxacin Mesylate Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Pefloxacin Mesylate Market Competitive Situation and Trends
        2.5.1 Pefloxacin Mesylate Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Pefloxacin Mesylate Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pefloxacin Mesylate as of 2022)
    2.7 Date of Key Manufacturers Enter into Pefloxacin Mesylate Market
    2.8 Key Manufacturers Pefloxacin Mesylate Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Pefloxacin Mesylate Status and Outlook by Region
    3.1 Global Pefloxacin Mesylate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Pefloxacin Mesylate Historic Market Size by Region
        3.2.1 Global Pefloxacin Mesylate Sales in Volume by Region (2018-2023)
        3.2.2 Global Pefloxacin Mesylate Sales in Value by Region (2018-2023)
        3.2.3 Global Pefloxacin Mesylate Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Pefloxacin Mesylate Forecasted Market Size by Region
        3.3.1 Global Pefloxacin Mesylate Sales in Volume by Region (2024-2029)
        3.3.2 Global Pefloxacin Mesylate Sales in Value by Region (2024-2029)
        3.3.3 Global Pefloxacin Mesylate Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Pefloxacin Mesylate by Application
    4.1 Pefloxacin Mesylate Market Segment by Application
        4.1.1 Hospital Pharmacy
        4.1.2 Retail Pharmacy
        4.1.3 Others
    4.2 Global Pefloxacin Mesylate Market Size by Application
        4.2.1 Global Pefloxacin Mesylate Market Size Overview by Application (2018-2029)
        4.2.2 Global Pefloxacin Mesylate Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Pefloxacin Mesylate Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Pefloxacin Mesylate Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Pefloxacin Mesylate Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Pefloxacin Mesylate Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Pefloxacin Mesylate Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Pefloxacin Mesylate Sales Breakdown by Application (2018-2023)

 5 North America Pefloxacin Mesylate by Country
    5.1 North America Pefloxacin Mesylate Historic Market Size by Country
        5.1.1 North America Pefloxacin Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Pefloxacin Mesylate Sales in Volume by Country (2018-2023)
        5.1.3 North America Pefloxacin Mesylate Sales in Value by Country (2018-2023)
    5.2 North America Pefloxacin Mesylate Forecasted Market Size by Country
        5.2.1 North America Pefloxacin Mesylate Sales in Volume by Country (2024-2029)
        5.2.2 North America Pefloxacin Mesylate Sales in Value by Country (2024-2029)

 6 Europe Pefloxacin Mesylate by Country
    6.1 Europe Pefloxacin Mesylate Historic Market Size by Country
        6.1.1 Europe Pefloxacin Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Pefloxacin Mesylate Sales in Volume by Country (2018-2023)
        6.1.3 Europe Pefloxacin Mesylate Sales in Value by Country (2018-2023)
    6.2 Europe Pefloxacin Mesylate Forecasted Market Size by Country
        6.2.1 Europe Pefloxacin Mesylate Sales in Volume by Country (2024-2029)
        6.2.2 Europe Pefloxacin Mesylate Sales in Value by Country (2024-2029)

 7 Asia-Pacific Pefloxacin Mesylate by Region
    7.1 Asia-Pacific Pefloxacin Mesylate Historic Market Size by Region
        7.1.1 Asia-Pacific Pefloxacin Mesylate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Pefloxacin Mesylate Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Pefloxacin Mesylate Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Pefloxacin Mesylate Forecasted Market Size by Region
        7.2.1 Asia-Pacific Pefloxacin Mesylate Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Pefloxacin Mesylate Sales in Value by Region (2024-2029)

 8 Latin America Pefloxacin Mesylate by Country
    8.1 Latin America Pefloxacin Mesylate Historic Market Size by Country
        8.1.1 Latin America Pefloxacin Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Pefloxacin Mesylate Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Pefloxacin Mesylate Sales in Value by Country (2018-2023)
    8.2 Latin America Pefloxacin Mesylate Forecasted Market Size by Country
        8.2.1 Latin America Pefloxacin Mesylate Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Pefloxacin Mesylate Sales in Value by Country (2024-2029)

 9 Middle East and Africa Pefloxacin Mesylate by Country
    9.1 Middle East and Africa Pefloxacin Mesylate Historic Market Size by Country
        9.1.1 Middle East and Africa Pefloxacin Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Pefloxacin Mesylate Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Pefloxacin Mesylate Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Pefloxacin Mesylate Forecasted Market Size by Country
        9.2.1 Middle East and Africa Pefloxacin Mesylate Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Pefloxacin Mesylate Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 AdvaCare Pharma
        10.1.1 AdvaCare Pharma Company Information
        10.1.2 AdvaCare Pharma Introduction and Business Overview
        10.1.3 AdvaCare Pharma Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 AdvaCare Pharma Pefloxacin Mesylate Products Offered
        10.1.5 AdvaCare Pharma Recent Development
    10.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
        10.2.1 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Company Information
        10.2.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Introduction and Business Overview
        10.2.3 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Products Offered
        10.2.5 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Development
    10.3 Ruiyang Pharmaceutical Co., Ltd.
        10.3.1 Ruiyang Pharmaceutical Co., Ltd. Company Information
        10.3.2 Ruiyang Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.3.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Products Offered
        10.3.5 Ruiyang Pharmaceutical Co., Ltd. Recent Development
    10.4 Yichang Renfu Pharmaceutical Co., Ltd.
        10.4.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
        10.4.2 Yichang Renfu Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.4.3 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Products Offered
        10.4.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Development
    10.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
        10.5.1 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Company Information
        10.5.2 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Introduction and Business Overview
        10.5.3 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Products Offered
        10.5.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Development
    10.6 CommScope Pharmaceutical Co., Ltd.
        10.6.1 CommScope Pharmaceutical Co., Ltd. Company Information
        10.6.2 CommScope Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.6.3 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Products Offered
        10.6.5 CommScope Pharmaceutical Co., Ltd. Recent Development
    10.7 Beijing Shuanglu Pharmaceutical Co., Ltd.
        10.7.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
        10.7.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.7.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Products Offered
        10.7.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development
    10.8 Beijing Sihuan Pharmaceutical Co., Ltd.
        10.8.1 Beijing Sihuan Pharmaceutical Co., Ltd. Company Information
        10.8.2 Beijing Sihuan Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.8.3 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Products Offered
        10.8.5 Beijing Sihuan Pharmaceutical Co., Ltd. Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Pefloxacin Mesylate Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Pefloxacin Mesylate Industrial Chain Analysis
    11.4 Pefloxacin Mesylate Market Dynamics
        11.4.1 Pefloxacin Mesylate Industry Trends
        11.4.2 Pefloxacin Mesylate Market Drivers
        11.4.3 Pefloxacin Mesylate Market Challenges
        11.4.4 Pefloxacin Mesylate Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Pefloxacin Mesylate Distributors
    12.3 Pefloxacin Mesylate Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Tablet
    Table 2. Major Company of Capsule
    Table 3. Major Company of Injection
    Table 4. Global Pefloxacin Mesylate Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Pefloxacin Mesylate Sales by Type (2018-2023) & (K Units)
    Table 6. Global Pefloxacin Mesylate Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Pefloxacin Mesylate Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Pefloxacin Mesylate Market Share in Value by Type (2018-2023)
    Table 9. Global Pefloxacin Mesylate Price by Type (2018-2023) & (US$/Unit)
    Table 10. Global Pefloxacin Mesylate Sales by Type (2024-2029) & (K Units)
    Table 11. Global Pefloxacin Mesylate Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Pefloxacin Mesylate Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Pefloxacin Mesylate Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Pefloxacin Mesylate Price by Type (2024-2029) & (US$/Unit)
    Table 15. North America Pefloxacin Mesylate Sales by Type (2018-2023) & (K Units)
    Table 16. North America Pefloxacin Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Pefloxacin Mesylate Sales (K Units) by Type (2018-2023)
    Table 18. Europe Pefloxacin Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Pefloxacin Mesylate Sales (K Units) by Type (2018-2023)
    Table 20. Asia-Pacific Pefloxacin Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Pefloxacin Mesylate Sales (K Units) by Type (2018-2023)
    Table 22. Latin America Pefloxacin Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Pefloxacin Mesylate Sales (K Units) by Type (2018-2023)
    Table 24. Middle East and Africa Pefloxacin Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Pefloxacin Mesylate Sales by Company (2018-2023) & (K Units)
    Table 26. Global Pefloxacin Mesylate Sales Share by Company (2018-2023)
    Table 27. Global Pefloxacin Mesylate Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Pefloxacin Mesylate Revenue Share by Company (2018-2023)
    Table 29. Global Market Pefloxacin Mesylate Price by Company (2018-2023) & (US$/Unit)
    Table 30. Global Pefloxacin Mesylate Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Pefloxacin Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pefloxacin Mesylate as of 2022)
    Table 33. Date of Key Manufacturers Enter into Pefloxacin Mesylate Market
    Table 34. Key Manufacturers Pefloxacin Mesylate Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Pefloxacin Mesylate Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Pefloxacin Mesylate Sales by Region (2018-2023) & (K Units)
    Table 38. Global Pefloxacin Mesylate Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Pefloxacin Mesylate Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Pefloxacin Mesylate Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 42. Global Pefloxacin Mesylate Sales by Region (2024-2029) & (K Units)
    Table 43. Global Pefloxacin Mesylate Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Pefloxacin Mesylate Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Pefloxacin Mesylate Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
    Table 47. Global Pefloxacin Mesylate Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Pefloxacin Mesylate Sales by Application (2018-2023) & (K Units)
    Table 49. Global Pefloxacin Mesylate Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Pefloxacin Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Pefloxacin Mesylate Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Pefloxacin Mesylate Price by Application (2018-2023) & (US$/Unit)
    Table 53. Global Pefloxacin Mesylate Sales by Application (2024-2029) & (K Units)
    Table 54. Global Pefloxacin Mesylate Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Pefloxacin Mesylate Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Pefloxacin Mesylate Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Pefloxacin Mesylate Price by Application (2024-2029) & (US$/Unit)
    Table 58. North America Pefloxacin Mesylate Sales by Application (2018-2023) (K Units) 
    Table 59. North America Pefloxacin Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Pefloxacin Mesylate Sales by Application (2018-2023) (K Units) 
    Table 61. Europe Pefloxacin Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Pefloxacin Mesylate Sales by Application (2018-2023) (K Units) 
    Table 63. Asia-Pacific Pefloxacin Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Pefloxacin Mesylate Sales by Application (2018-2023) (K Units) 
    Table 65. Latin America Pefloxacin Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Pefloxacin Mesylate Sales by Application (2018-2023) (K Units) 
    Table 67. Middle East and Africa Pefloxacin Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Pefloxacin Mesylate Sales by Country (2018-2023) & (K Units)
    Table 69. North America Pefloxacin Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Pefloxacin Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Pefloxacin Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Pefloxacin Mesylate Sales by Country (2024-2029) & (K Units)
    Table 73. North America Pefloxacin Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Pefloxacin Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Pefloxacin Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Pefloxacin Mesylate Sales by Country (2018-2023) & (K Units)
    Table 77. Europe Pefloxacin Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Pefloxacin Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Pefloxacin Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Pefloxacin Mesylate Sales by Country (2024-2029) & (K Units)
    Table 81. Europe Pefloxacin Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Pefloxacin Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Pefloxacin Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Pefloxacin Mesylate Sales by Region (2018-2023) & (K Units)
    Table 85. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Pefloxacin Mesylate Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Pefloxacin Mesylate Sales by Region (2024-2029) & (K Units)
    Table 89. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Pefloxacin Mesylate Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Pefloxacin Mesylate Sales by Country (2018-2023) & (K Units)
    Table 93. Latin America Pefloxacin Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Pefloxacin Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Pefloxacin Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Pefloxacin Mesylate Sales by Country (2024-2029) & (K Units)
    Table 97. Latin America Pefloxacin Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Pefloxacin Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Pefloxacin Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Pefloxacin Mesylate Sales by Country (2018-2023) & (K Units)
    Table 101. Middle East and Africa Pefloxacin Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Pefloxacin Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Pefloxacin Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Pefloxacin Mesylate Sales by Country (2024-2029) & (K Units)
    Table 105. Middle East and Africa Pefloxacin Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Pefloxacin Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Pefloxacin Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 108. AdvaCare Pharma Company Information
    Table 109. AdvaCare Pharma Introduction and Business Overview
    Table 110. AdvaCare Pharma Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 111. AdvaCare Pharma Pefloxacin Mesylate Product
    Table 112. AdvaCare Pharma Recent Development
    Table 113. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Company Information
    Table 114. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Introduction and Business Overview
    Table 115. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 116. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product
    Table 117. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Development
    Table 118. Ruiyang Pharmaceutical Co., Ltd. Company Information
    Table 119. Ruiyang Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 120. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 121. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
    Table 122. Ruiyang Pharmaceutical Co., Ltd. Recent Development
    Table 123. Yichang Renfu Pharmaceutical Co., Ltd. Company Information
    Table 124. Yichang Renfu Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 125. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 126. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
    Table 127. Yichang Renfu Pharmaceutical Co., Ltd. Recent Development
    Table 128. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Company Information
    Table 129. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Introduction and Business Overview
    Table 130. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 131. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product
    Table 132. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Development
    Table 133. CommScope Pharmaceutical Co., Ltd. Company Information
    Table 134. CommScope Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 135. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 136. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
    Table 137. CommScope Pharmaceutical Co., Ltd. Recent Development
    Table 138. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
    Table 139. Beijing Shuanglu Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 140. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 141. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
    Table 142. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development
    Table 143. Beijing Sihuan Pharmaceutical Co., Ltd. Company Information
    Table 144. Beijing Sihuan Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 145. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 146. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
    Table 147. Beijing Sihuan Pharmaceutical Co., Ltd. Recent Development
    Table 148. Key Raw Materials Lists
    Table 149. Raw Materials Key Suppliers Lists
    Table 150. Pefloxacin Mesylate Market Trends
    Table 151. Pefloxacin Mesylate Market Drivers
    Table 152. Pefloxacin Mesylate Market Challenges
    Table 153. Pefloxacin Mesylate Market Restraints
    Table 154. Pefloxacin Mesylate Distributors List
    Table 155. Pefloxacin Mesylate Downstream Customers
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pefloxacin Mesylate Product Picture
    Figure 2. Global Pefloxacin Mesylate Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Pefloxacin Mesylate Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Pefloxacin Mesylate Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Tablet
    Figure 6. Global Tablet Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Capsule
    Figure 8. Global Capsule Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Injection
    Figure 10. Global Injection Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Global Pefloxacin Mesylate Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Pefloxacin Mesylate Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Pefloxacin Mesylate Sales Market Share in Volume by Type in 2022
    Figure 14. North America Pefloxacin Mesylate Sales Market Share in Value by Type in 2022
    Figure 15. Europe Pefloxacin Mesylate Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Pefloxacin Mesylate Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Pefloxacin Mesylate Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Pefloxacin Mesylate Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Pefloxacin Mesylate Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Pefloxacin Mesylate Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Pefloxacin Mesylate Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Pefloxacin Mesylate Revenue in 2022
    Figure 25. Pefloxacin Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Hospital Pharmacy
    Figure 27. Global Hospital Pharmacy Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Retail Pharmacy
    Figure 29. Global Retail Pharmacy Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Product Picture of Others
    Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 32. Global Pefloxacin Mesylate Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global Pefloxacin Mesylate Sales Market Share by Application in 2022 & 2029
    Figure 34. North America Pefloxacin Mesylate Sales Market Share in Volume by Application in 2022
    Figure 35. North America Pefloxacin Mesylate Sales Market Share in Value by Application in 2022
    Figure 36. Europe Pefloxacin Mesylate Sales Market Share in Volume by Application in 2022
    Figure 37. Europe Pefloxacin Mesylate Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific Pefloxacin Mesylate Sales Market Share in Value by Application in 2022
    Figure 40. Latin America Pefloxacin Mesylate Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America Pefloxacin Mesylate Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa Pefloxacin Mesylate Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Pefloxacin Mesylate Manufacturing Cost Structure
    Figure 45. Pefloxacin Mesylate Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed

Pefloxacin Mesylate is a quinolone antibacterial drug that can treat various infections caused by pefloxacin-sensitive bacteria, such as urinary tract infections and respiratory tract infections.

Pefloxacin Mesylate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pefloxacin Mesylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.

Pefloxacin Mesylate can be divided into Tablet, Capsule and Injection,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.

Segment by Type
Tablet
Capsule
Injection

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 99 Pages

Report ld: 1347505

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License